Founder Lodge | Cognito Therapeutics, Inc. raises $73,000,000 at …

Mar 23, 2023 · Cognito Therapeutics, Inc. raises $73,000,000 at Series B on 2023-03-23 in Medical Equipment Manufacturing, industry founded/co-founded by Brent Vaughan

CouponFollow Extension

$73000000
OFF

Founder Lodge | Cognito Therapeutics, Inc. Raises $73,000,000 At …

6 days from now

Mar 23, 2023 · Cognito Therapeutics, Inc. raises $73,000,000 at Series B on 2023-03-23 in Medical Equipment Manufacturing, industry founded/co-founded by Brent Vaughan

founderlodge.com

$73
OFF

Neurotechnology Company Cognito Therapeutics Scores $73M

6 days from now

Mar 23, 2023 · Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored $73 million in a Series B funding round led by FoundersX …

mobihealthnews.com

$73000000
OFF

Series B - Cognito Therapeutics - 2023-03-22 - Crunchbase

6 days from now

Mar 22, 2023 · Cognito Therapeutics raised $73000000 on 2023-03-22 in Series B. FoundersX Ventures FoundersX Ventures, a cross-stage venture capital firm based in Menlo Park with …

crunchbase.com

$73
OFF

Cognito Therapeutics Closes $73M Series B Financing

6 days from now

Mar 23, 2023 · Cognito Therapeutics announced a $73M Series B financing round led by FoundersX Ventures, bringing the total amount raised since inception to $93 million. All …

g-medtech.com

$73
OFF

Cognito Therapeutics Raises $73M Series B To Advance …

6 days from now

Cognito Therapeutics Raises $73M Series B to Advance Neurotechnology Platform for Alzheimer’s Disease. ... Chief Medical and Scientific Officer of Medtronic and Helen Liang, …

vcaonline.com

$73
OFF

Firm Advises Cognito Therapeutics On $73 Million Series B Financing

6 days from now

Mar 31, 2023 · On March 22, 2023, neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led by FoundersX Ventures with …

wsgr.com

$73
OFF

Cognito Therapeutics Raises $73M In Series B Funding For …

6 days from now

Mar 23, 2023 · Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, has completed a $73M Series B financing round led by …

mpo-mag.com

$73
OFF

Neurotechnology Company Cognito Therapeutics Scores $73M

6 days from now

Mar 27, 2023 · Cognito Therapeutics, a Massachusetts-based startup focused on using noninvasive neuromodulation to treat neurodegenerative diseases, has raised $73 million in a …

distilnfo.com

$35
OFF

Cognito Nets $35 Million To Advance Alzheimer's DTx Trial

6 days from now

Jan 29, 2024 · Cognito Therapeutics has raised $35 million to advance its digital therapeutic (DTx) for Alzheimer's disease, the company's CEO Brent Vaughan told FirstWord HealthTech …

firstwordhealthtech.com

$73
OFF

Neurotechnology Company Cognito Therapeutics Scores $73M

6 days from now

Mar 23, 2023 · Originally published by MobiHealthNews on March 23, 2023. Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative …

agetech.news

$670000
OFF

Dozens Arrested Had Mob Ties In Gambling Ring Bust, Authorities Say

6 days from now

Dec 5, 2016 · Authorities seized $670,000 from a safety deposit box held by Cicalese and his wife, Rose, 72, who was also charged. The investigation began in April 2003 as a probe into …

northjersey.com

$2000000
OFF

Founder Lodge | Cognito Health Raises $2,000,000 At Seed On 2024 …

6 days from now

Mar 7, 2024 · Cognito Health raises $2,000,000 at Seed on 2024-03-07 in Mental Health Care, industry founded/co-founded by Armon Arani

founderlodge.com

FAQs about Founder Lodge | Cognito Therapeutics, Inc. raises $73,000,000 at … Coupon?

Does Cognito therapeutics have a series B financing?

CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. ...

Who is Cognito Therapeutics?

About Cognito Therapeutics Cognito Therapeutics is a clinical-stage neurotechnology company developing disease-modifying therapeutic approaches to treat neurodegenerative disorders. Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. ...

Where is Cognito based?

The Company’s lead therapy is currently in a pivotal study in Alzheimer’s Disease and was awarded FDA Breakthrough Device Designation. Cognito is based in Cambridge, MA. For more information, visit www.cognitotx.com. Follow us on Twitter at @cognitotx. ...

Who will join Cognito's Board of directors?

In addition to the financing, Dr. Rick Kuntz, MD, MSc, former Senior Vice President, Chief Medical and Scientific Officer of Medtronic and Helen Liang, Founder & Managing Partner at FoundersX, will join Cognito’s Board of Directors. Dr. ...

Who owns Alzheimer's Drug Discovery Foundation (ADDF)?

Top-tier investor syndicate led by FoundersX Ventures, with participation from all existing investors and new investors Alzheimer’s Drug Discovery Foundation (ADDF), Starbloom Capital, IAG Capital and WS Investment Company. ...

Can a non-drug neuromodulation intervention help treat Alzheimer's & Cognito?

“A non-drug neuromodulation intervention has the potential to better address the complex nature of neurodegenerative diseases such as Alzheimer’s and Cognito is well-positioned to be a leader in this new paradigm,” said Helen Liang, Founder & Managing Partner, FoundersX Ventures. ...